Brief: Tevogen Bio Confirms Ongoing Efficacy Of TVGN 489 Against Dominant Flirt Strains Of SARS-CoV-2
06/06/2024 20:56
June 6 (Reuters) - Tevogen Bio Holdings Inc TVGN.O :
* TEVOGEN BIO CONFIRMS ONGOING EFFICACY OF TVGN 489, ITS
INVESTIGATIONAL ALLOGENEIC OFF-THE-SHELF IMMUNOTHERAPY, AGAINST
DOMINANT FLIRT STRAINS OF SARS-COV-2
Source text for Eikon: ID:nGNXbwGZk9
Further company coverage: TVGN.O